5-lipoxygenase-activating protein (FLAP) inhibitors

Details for Australian Patent Application No. 2006311796 (hide)

Owner Amira Pharmaceuticals, Inc.

Inventors Moran, Mark; Li, Yiwei; Prasit, Petpiboon Peppi; Stock, Nicholas Simon; Hutchinson, John H.; Zunic, Jasmine Eleanor; Haddach, Mustapha; Evans, Jillian F.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2006311796

PCT Pub. Number WO2007/056220

Priority 60/747,174 12.05.06 US; 60/823,344 23.08.06 US; 60/734,030 04.11.05 US

Filing date 3 November 2006

Wipo publication date 18 May 2007

International Classifications

A61K 31/501 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/427 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/4439 (2006.01)

A61K 31/497 (2006.01)

C07D 403/02 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 417/02 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

26 June 2008 PCT application entered the National Phase

  PCT publication WO2007/056220 Priority application(s): WO2007/056220

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006311797-Aminopyrimidines useful as kinase inhibitors

2006311795-[4-(6-halo-7-substituted-2,4-dioxo-1,4-di hydro2h-quinazolin-3-yl)-phenyl]-5-chloro-thio phen-2-yl-sulfonylureas and forms and methods related thereto